These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1112 related items for PubMed ID: 11016654
1. Loss of p27Kip1 from cyclin E/cyclin-dependent kinase (CDK) 2 but not from cyclin D1/CDK4 complexes in cells transformed by polyamine biosynthetic enzymes. Ravanko K, Järvinen K, Paasinen-Sohns A, Hölttä E. Cancer Res; 2000 Sep 15; 60(18):5244-53. PubMed ID: 11016654 [Abstract] [Full Text] [Related]
2. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein. Reshetnikova G, Barkan R, Popov B, Nikolsky N, Chang LS. Exp Cell Res; 2000 Aug 25; 259(1):35-53. PubMed ID: 10942577 [Abstract] [Full Text] [Related]
3. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate. Liang YC, Lin-Shiau SY, Chen CF, Lin JK. J Cell Biochem; 1999 Oct 01; 75(1):1-12. PubMed ID: 10462699 [Abstract] [Full Text] [Related]
4. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells. Cereseto A, Washington Parks R, Rivadeneira E, Franchini G. Oncogene; 1999 Apr 15; 18(15):2441-50. PubMed ID: 10229195 [Abstract] [Full Text] [Related]
5. Effect of elevated levels of ornithine decarboxylase on cell cycle progression in skin. Gilmour SK, Birchler M, Smith MK, Rayca K, Mostochuk J. Cell Growth Differ; 1999 Nov 15; 10(11):739-48. PubMed ID: 10593650 [Abstract] [Full Text] [Related]
6. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells. Morris TA, DeLorenzo RJ, Tombes RM. Exp Cell Res; 1998 May 01; 240(2):218-27. PubMed ID: 9596994 [Abstract] [Full Text] [Related]
7. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells. Orend G, Hunter T, Ruoslahti E. Oncogene; 1998 May 01; 16(20):2575-83. PubMed ID: 9632134 [Abstract] [Full Text] [Related]
8. Retinoic acid-mediated growth arrest of EBV-immortalized B lymphocytes is associated with multiple changes in G1 regulatory proteins: p27Kip1 up-regulation is a relevant early event. Zancai P, Cariati R, Rizzo S, Boiocchi M, Dolcetti R. Oncogene; 1998 Oct 08; 17(14):1827-36. PubMed ID: 9778049 [Abstract] [Full Text] [Related]
9. Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (Cdk) inhibitor by cyclin E/Cdk2. Morisaki H, Fujimoto A, Ando A, Nagata Y, Ikeda K, Nakanishi M. Biochem Biophys Res Commun; 1997 Nov 17; 240(2):386-90. PubMed ID: 9388487 [Abstract] [Full Text] [Related]
10. Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells. Mann DJ, Higgins T, Jones NC, Rozengurt E. Oncogene; 1997 Apr 17; 14(15):1759-66. PubMed ID: 9150381 [Abstract] [Full Text] [Related]
11. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity. Coppock DL, Buffolino P, Kopman C, Nathanson L. Exp Cell Res; 1995 Nov 17; 221(1):92-102. PubMed ID: 7589260 [Abstract] [Full Text] [Related]
13. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells. Kamesaki H, Nishizawa K, Michaud GY, Cossman J, Kiyono T. J Immunol; 1998 Jan 15; 160(2):770-7. PubMed ID: 9551912 [Abstract] [Full Text] [Related]
14. Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells. Tsihlias J, Zhang W, Bhattacharya N, Flanagan M, Klotz L, Slingerland J. Oncogene; 2000 Feb 03; 19(5):670-9. PubMed ID: 10698512 [Abstract] [Full Text] [Related]
15. Downregulation of cyclin D1 alters cdk 4- and cdk 2-specific phosphorylation of retinoblastoma protein. Yu B, Lane ME, Pestell RG, Albanese C, Wadler S. Mol Cell Biol Res Commun; 2000 Jun 03; 3(6):352-9. PubMed ID: 11032757 [Abstract] [Full Text] [Related]
16. Antiproliferative function of p27kip1 is frequently inhibited in highly malignant Burkitt's lymphoma cells. Barnouin K, Fredersdorf S, Eddaoudi A, Mittnacht S, Pan LX, Du MQ, Lu X. Oncogene; 1999 Nov 04; 18(46):6388-97. PubMed ID: 10597239 [Abstract] [Full Text] [Related]
17. Loss of cell cycle control by deregulation of cyclin-dependent kinase 2 kinase activity in Evi-1 transformed fibroblasts. Kilbey A, Stephens V, Bartholomew C. Cell Growth Differ; 1999 Sep 04; 10(9):601-10. PubMed ID: 10511310 [Abstract] [Full Text] [Related]
18. Cell cycle arrest induced by the vitamin D(3) analog EB1089 in NCI-H929 myeloma cells is associated with induction of the cyclin-dependent kinase inhibitor p27. Park WH, Seol JG, Kim ES, Jung CW, Lee CC, Binderup L, Koeffler HP, Kim BK, Lee YY. Exp Cell Res; 2000 Feb 01; 254(2):279-86. PubMed ID: 10640426 [Abstract] [Full Text] [Related]
19. High-density growth arrest in Ras-transformed cells: low Cdk kinase activities in spite of absence of p27(Kip) Cdk-complexes. Groth A, Willumsen BM. Cell Signal; 2005 Sep 01; 17(9):1063-73. PubMed ID: 15993748 [Abstract] [Full Text] [Related]
20. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells. Said TK, Medina D. Mol Carcinog; 1998 Jun 01; 22(2):128-43. PubMed ID: 9655257 [Abstract] [Full Text] [Related] Page: [Next] [New Search]